Von Hoff, Daniel D <br/><br/>
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.  [electronic resource] 

 -  The New England journal of medicine  Sep 2009 
 - 1164-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa0905360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anilides<br/>Antineoplastic Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Carcinoma, Basal Cell--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Expression<br/>Hedgehog Proteins--antagonists & inhibitors<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Patched Receptors<br/>Patched-1 Receptor<br/>Polymerase Chain Reaction<br/>Pyridines<br/>RNA, Messenger--metabolism<br/>Receptors, Cell Surface--genetics<br/>Sequence Analysis, DNA<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--drug therapy<br/>Transcription Factors--genetics<br/>Zinc Finger Protein GLI1